Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
ALT
CTMX
Add up to 3 more stocks
ALT
Altimmune, Inc.
0.00%
$2.670.00Delayed quote: Oct 6, 2026, 11:00 AM EDT
Market Cap
$519.25M
52W Range
$2.56 - $6.44
CTMX
CytomX Therapeutics, Inc.
+0.39%
$2.59+0.01Delayed quote: Oct 6, 2026, 11:00 AM EDT
Market Cap
$563.87M
52W Range
$2.48 - $8.21
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | N/A | N/A |
| Forward P/E | N/A | N/A |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 1.09 | 1.87 |
| P/S Ratio | 16749.86 | 30.81 |
| P/FCF Ratio | N/A | N/A |
| EV/EBITDA | N/A | N/A |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 100.0% | 98.6% |
| Operating Margin | -230461.0% | -29.4% |
| Net Margin | -296000.0% | -435.2% |
| ROE | -19.4% | -26.4% |
| ROA | -17.4% | -20.9% |
| ROIC | -19.5% | -25.4% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 26.78 | 9.36 |
| Quick Ratio | 26.78 | 9.36 |
| Debt/Equity | 0.08 | 0.02 |
| Interest Coverage | -57.76 | N/A |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.